U-74500A
Grundinformationen
- CAS
110101-65-0- Standard-SMILES
CCN(CC)c1ccc(N(CC)CC)c(N2CCN(CC(=O)[C@H]3[C@H](C)C[C@H]4[C@@H]5CCC6=CC(=O)C=C[C@]6(C)C5=CC[C@@]43C)CC2)n1.Cl- InChIKey
BINFIZGKEZTZIO-ZRTOZFNYSA-N- Summenformel
- C39H58ClN5O2
- Durchschnittliche Molmasse
- 664,4 g/mol
- Monoisotopische Masse
- 663,4279038
Überblick
potent inhibitor of iron-dependent lipid peroxidation; has excellent activity in in vivo models of experimental CNS trauma & ischemia; structure given in first source; RN given is for 3,6-bis(diethylamino) cpd; Cancer Lett 1992;64(1):61-6 uses 5,6-bis(diethylamino) cpd for U 74500A
Namen und Bezeichner
- Bevorzugter Name
- U-74500A
- IUPAC
- (8S,10S,13S,14S,16R,17S)-17-[2-[4-[3,6-bis(diethylamino)-2-pyridinyl]piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one;hydrochloride
Namen und Synonyme
U-74500A110101-65-0U 74500AIDW4RCM01LU74500APregna-1,4,9(11)-triene-3,20-dione, 21-(4-(3,6-bis(diethylamino)-2-pyridinyl)-1-piperazinyl)-16-methyl-, hydrochloride, (16alpha)-U74500EU-74500ERefChem:192807UNII-IDW4RCM01L21-(4-(3,6-Bis(diethylamino)-2-pyridinyl)-1-piperazinyl)-16-methylpregna-1,4,9(11)triene-3,20-dione hcl21-(4-(5,6-Bis(diethylamino)-2-pyridinyl)-1-piperazinyl)-16-methylpregna-1,4,9(11)triene-3,20-dione hcl
Weitere Namen anzeigen
SCHEMBL31690230DTXSID70911497(8S,10S,13S,14S,16R,17S)-17-[2-[4-[3,6-bis(diethylamino)pyridin-2-yl]piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one;hydrochlorideQ2728067421-{4-[3,6-Bis(diethylamino)pyridin-2-yl]piperazin-1-yl}-16-methylpregna-1,4,9(11)-triene-3,20-dione--hydrogen chloride (1/1)21-{4-[3,6-Bis(diethylamino)pyridin-2-yl]piperazin-1-yl}-16alpha-methylpregna-1,4,9(11)-triene-3,20-dione--hydrogen chloride (1/1)PREGNA-1,4,9(11)-TRIENE-3,20-DIONE, 21-(4-(3,6-BIS(DIETHYLAMINO)-2-PYRIDINYL)-1-PIPERAZINYL)-16-METHYL-, HYDROCHLORIDE, (16.ALPHA.)-
Datenbank-Bezeichner
- CAS
110101-65-0
Eigenschaften
Berechnete Struktureigenschaften
- Polarare Oberfläche (TPSA)
- 60 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 7
- Frei drehbare Bindungen
- 10
- Schwere Atome
- 47
- Formalladung
- 0
- Komplexität
- 1.230
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological Classification
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief.
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.
Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.
Zugehörige Reaktionen
0
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Notizen zur Verbindung
Wird geladen…